BIOLASE, Inc. (BIOLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 11, 2025, 9:30 AM EDT
BIOLASE Market Cap
BIOLASE has a market cap or net worth of $3.66 thousand as of August 12, 2025. Its market cap has decreased by -99.86% in one year.
Market Cap
3.66K
Enterprise Value
15.60M
Revenue
46.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 12, 1992, BIOLASE's market cap has decreased from 43.61M to 3.66K, a decrease of -99.99%. That is a compound annual growth rate of -24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 3.66K | -99.17% |
| Dec 31, 2024 | 439.17K | -88.54% |
| Dec 29, 2023 | 3.83M | -23.61% |
| Dec 30, 2022 | 5.02M | -91.61% |
| Dec 31, 2021 | 59.78M | 53.42% |
| Dec 31, 2020 | 38.96M | 127.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |